Skip to main content

HEALTH

  • Bydureon officially hits market

    SAN DIEGO — Amylin Pharmaceuticals and Alkermes announced that their Type 2 diabetes treatment now is available by prescription in U.S. pharmacies.

    Bydureon (exenatide extended-release for injectable suspension) received approval from the Food and Drug Administration on Jan. 27 as an adjunct to diet and exercise to improve glycemic control in adults with Type 2 diabetes.

  • SymphonyIRI Group: Focus on in-store merchandising continues to bear fruit

    CHICAGO — According to “Merchandising Trends: Driving Consumption through Shopper Marketing,” a new report published earlier this week by SymphonyIRI Group, merchandising continues to play an important role at retail. In 2011, 47% of consumer packaged goods categories enjoyed increased merchandising support, including displays, feature ads, feature and display combined, and price reduction only.

  • FDA issues warning on PPI, H2 blocker antacids: May increase risk of CDAD

    SILVER SPRING, Md. — The Food and Drug Administration on Wednesday issued a public warning that the use of proton-pump inhibitors or H2 blockers may be associated with an increased risk of Clostridium difficile–associated diarrhea, or CDAD.

    Patients should immediately contact their healthcare professional and seek care if they take PPIs and develop diarrhea that does not improve, the agency stated.

  • Center for Reproductive Rights files to reopen 2005 Plan B contraceptive suit

    NEW YORK — The Center for Reproductive Rights on Wednesday asked a federal court to reopen its 2005 lawsuit against the Food and Drug Administration for imposing age restrictions on emergency contraceptive drugs. Presently, emergency contraceptives, like Plan B One Step, are available behind a pharmacy counter for women 17 years and older but require a prescription for women under the age of 17 years.

  • Walgreens direct messaging those social consumers 'checking in' at its stores

    NEW YORK — Walgreens in January has been utilizing a new mobile advertising tool to push out messages targeting consumers who just "checked in" at one of its locations, according to a report published in Ad Age Wednesday.

    According to the report, Walgreens sent out 5,000 messages in January via Twitter stating: "Check out Halls' new cough drops in the cold aisle."

  • Social media strategist Robin Leedy takes on six new brands

    MOUNT KISCO, N.Y. — Social media strategist Robin Leedy & Associates, a public relations and social media marketing agency, on Wednesday announced the signing of six clients featuring several brands in the health and beauty space, including FeverAll acetaminophen suppositories by Actavis; Replens by Lil’ Drug Store; SpermCheck Fertility; The Natural Dentist by Revive Personal Products; Redex’s Udderly Smooth; and Boiron USA brands Oscillococcinum, Arnicare and Camilia.

  • Diabetes Prevention and Control Alliance extended to Safeway stores in select markets

    MINNETONKA, Minn. — Another retailer has joined the UnitedHealth Group's Diabetes Prevention and Control Alliance, an initiative designed to help address the growing epidemic of prediabetes and Type 2 diabetes.

  • MusclePharm launches MMA Elite supplement line at Walmart

    DENVER — MusclePharm on Thursday announced its MMA Elite supplements powered by MusclePharm now are available in select Walmart stores. With the new partnership between MMA Elite — a mixed-martials arts brand licensed by Ultimate Brand Management — and MusclePharm, the new supplement line will be released in the Las Vegas area first and will then spread nationwide.

    The first two products to be featured are Perform Elite, a pre-workout product, and Recover Elite, a post-workout supplement, at a suggested retail price of $19.97 each.

Related Topics

X
This ad will auto-close in 10 seconds